XML 60 R39.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Customers that Represent Greater than Ten Percent of Gross Accounts Receivable (Detail) - Accounts Receivable - Credit Concentration Risk
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Novartis AG    
Concentration Risk [Line Items]    
Concentration risk percentage   20.00%
Distributor A    
Concentration Risk [Line Items]    
Concentration risk percentage 32.00% 14.00%
Regeneron Pharmaceuticals    
Concentration Risk [Line Items]    
Concentration risk percentage   12.00%
Distributor B    
Concentration Risk [Line Items]    
Concentration risk percentage 10.00% 10.00%